ANKS1B |
ankyrin repeat and sterile alpha motif domain containing 1B |
|
|
|
ARF1 |
ADP ribosylation factor 1 |
- Synthesis of PIPs at the plasma membrane
- Synthesis of PIPs at the Golgi membrane
- Nef Mediated CD4 Down-regulation
- trans-Golgi Network Vesicle Budding
- MHC class II antigen presentation
- Lysosome Vesicle Biogenesis
- Golgi Associated Vesicle Biogenesis
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
- Intra-Golgi traffic
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
|
- 1,3-Propanediol
- Guanosine-3'-monophosphate-5'-diphosphate
- Guanosine-5'-Triphosphate
- Guanosine-5'-Diphosphate
- Brefeldin A
- Myristic acid
- Glycerin
|
|
ARF6 |
ADP ribosylation factor 6 |
- TBC/RABGAPs
- Clathrin-mediated endocytosis
- MET receptor recycling
|
- 5'-Guanosine-Diphosphate-Monothiophosphate
- Guanosine-5'-Diphosphate
- Myristic acid
|
|
CTSG |
cathepsin G |
- Degradation of the extracellular matrix
- Activation of Matrix Metalloproteinases
- Metabolism of Angiotensinogen to Angiotensins
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Interleukin-1 processing
- Neutrophil degranulation
- Antimicrobial peptides
- Suppression of apoptosis
- Purinergic signaling in leishmaniasis infection
|
- Bis-Napthyl Beta-Ketophosphonic Acid
- 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid
|
|
DACH1 |
dachshund family transcription factor 1 |
|
|
|
DIRAS3 |
DIRAS family GTPase 3 |
|
|
|
DLG1 |
discs large MAGUK scaffold protein 1 |
- Trafficking of AMPA receptors
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- Ras activation upon Ca2+ influx through NMDA receptor
- NrCAM interactions
- Activation of Ca-permeable Kainate Receptor
- RAF/MAP kinase cascade
- Synaptic adhesion-like molecules
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
|
|
|
DLG4 |
discs large MAGUK scaffold protein 4 |
- Signaling by ERBB4
- Trafficking of AMPA receptors
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- Ras activation upon Ca2+ influx through NMDA receptor
- NrCAM interactions
- Activation of Ca-permeable Kainate Receptor
- RHO GTPases activate CIT
- RAF/MAP kinase cascade
- LGI-ADAM interactions
- Neurexins and neuroligins
- Neurexins and neuroligins
- Synaptic adhesion-like molecules
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
|
- Guanidine
- Guanosine-5'-Monophosphate
|
|
EIF3F |
eukaryotic translation initiation factor 3 subunit F |
- L13a-mediated translational silencing of Ceruloplasmin expression
- Translation initiation complex formation
- Formation of a pool of free 40S subunits
- Formation of the ternary complex, and subsequently, the 43S complex
- Ribosomal scanning and start codon recognition
- GTP hydrolysis and joining of the 60S ribosomal subunit
|
|
|
GLUL |
glutamate-ammonia ligase |
- Astrocytic Glutamate-Glutamine Uptake And Metabolism
- Glutamate and glutamine metabolism
|
- L-Glutamine
- Glutamic acid
|
|
GNA11 |
G protein subunit alpha 11 |
- PLC beta mediated events
- PLC beta mediated events
- G-protein activation
- Acetylcholine regulates insulin secretion
- Acetylcholine regulates insulin secretion
- G alpha (q) signalling events
- G alpha (q) signalling events
- ADP signalling through P2Y purinoceptor 1
- ADP signalling through P2Y purinoceptor 1
- Thromboxane signalling through TP receptor
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Thrombin signalling through proteinase activated receptors (PARs)
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
|
|
|
GNAI1 |
G protein subunit alpha i1 |
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- ADP signalling through P2Y purinoceptor 12
- Adrenaline,noradrenaline inhibits insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Regulation of insulin secretion
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
|
- Guanosine-5'-Diphosphate
- Tetrafluoroaluminate Ion
|
|
GNAQ |
G protein subunit alpha q |
- PLC beta mediated events
- PLC beta mediated events
- G-protein activation
- Acetylcholine regulates insulin secretion
- Acetylcholine regulates insulin secretion
- G alpha (q) signalling events
- G alpha (q) signalling events
- ADP signalling through P2Y purinoceptor 1
- ADP signalling through P2Y purinoceptor 1
- Thromboxane signalling through TP receptor
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Thrombin signalling through proteinase activated receptors (PARs)
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
|
|
|
JAK2 |
Janus kinase 2 |
- Interleukin-6 signaling
- Interleukin-6 signaling
- MAPK3 (ERK1) activation
- MAPK1 (ERK2) activation
- Prolactin receptor signaling
- Prolactin receptor signaling
- Signaling by SCF-KIT
- Signaling by Leptin
- RMTs methylate histone arginines
- Interleukin-3, Interleukin-5 and GM-CSF signaling
- Interleukin-3, Interleukin-5 and GM-CSF signaling
- RAF activation
- RAF/MAP kinase cascade
- Interleukin-4 and Interleukin-13 signaling
- IL-6-type cytokine receptor ligand interactions
- Signaling by moderate kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Cyclin D associated events in G1
- Interferon gamma signaling
- Regulation of IFNG signaling
- Regulation of IFNG signaling
- Interleukin-20 family signaling
- Interleukin-35 Signalling
- Signaling by Erythropoietin
- Interleukin-12 signaling
- Interleukin-12 signaling
- Interleukin-23 signaling
- Interleukin-23 signaling
- Interleukin-27 signaling
- Interleukin-27 signaling
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
- Erythropoietin activates Phospholipase C gamma (PLCG)
- Erythropoietin activates STAT5
- Erythropoietin activates RAS
- Erythropoietin activates RAS
- Interleukin receptor SHC signaling
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
- Signaling by CSF3 (G-CSF)
- Signaling by CSF3 (G-CSF)
- Potential therapeutics for SARS
- Inactivation of CSF3 (G-CSF) signaling
- Inactivation of CSF3 (G-CSF) signaling
- Growth hormone receptor signaling
- Growth hormone receptor signaling
- Factors involved in megakaryocyte development and platelet production
|
- 2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one
- XL019
- 5-phenyl-1H-indazol-3-amine
- 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide
- 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM
- Ruxolitinib
- Tofacitinib
- Baricitinib
- Entrectinib
- Fostamatinib
- Fedratinib
- Zanubrutinib
- Pralsetinib
|
|
MAP1A |
microtubule associated protein 1A |
|
|
|
MRPL28 |
mitochondrial ribosomal protein L28 |
- Mitochondrial translation initiation
- Mitochondrial translation elongation
- Mitochondrial translation elongation
- Mitochondrial translation termination
|
|
|
NDUFB10 |
NADH:ubiquinone oxidoreductase subunit B10 |
- Respiratory electron transport
- Complex I biogenesis
|
|
|
NME3 |
NME/NM23 nucleoside diphosphate kinase 3 |
- Interconversion of nucleotide di- and triphosphates
|
|
|
NTRK3 |
neurotrophic receptor tyrosine kinase 3 |
- Receptor-type tyrosine-protein phosphatases
- NTF3 activates NTRK3 signaling
- NTF3 activates NTRK3 signaling
- Signaling by NTRK3 (TRKC)
- Activated NTRK3 signals through PLCG1
- Activated NTRK3 signals through PLCG1
- Activated NTRK3 signals through RAS
- Activated NTRK3 signals through PI3K
- Activated NTRK3 signals through PI3K
- NTRK3 as a dependence receptor
|
- Entrectinib
- Fostamatinib
- Larotrectinib
- Pralsetinib
|
|
PCDH9 |
protocadherin 9 |
|
|
|
PON2 |
paraoxonase 2 |
- Synthesis of 5-eicosatetraenoic acids
|
|
|
PPP5C |
protein phosphatase 5 catalytic subunit |
- Negative regulation of MAPK pathway
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- ESR-mediated signaling
|
|
|
RFXAP |
regulatory factor X associated protein |
|
|
|
RPS6KA3 |
ribosomal protein S6 kinase A3 |
- ERK/MAPK targets
- CREB phosphorylation
- Senescence-Associated Secretory Phenotype (SASP)
- Senescence-Associated Secretory Phenotype (SASP)
- Recycling pathway of L1
- CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
- RSK activation
- RSK activation
- Gastrin-CREB signalling pathway via PKC and MAPK
|
- Acetylsalicylic acid
- Fostamatinib
|
|
SUGT1 |
SGT1 homolog, MIS12 kinetochore complex assembly cochaperone |
- The NLRP3 inflammasome
- Purinergic signaling in leishmaniasis infection
|
|
|